Dietary vitamin E and C supplementation prevents fructose induced hypertension in rats

Molecular and Cellular Biochemistry

Volumn 241, Issue 1-2, 2002, Pages 107-114

  Vasdev, S ^a   Gill, V ^a   Parai, S ^a   Longerich, L ^a   Gadag, V ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Aldehydes; Hypertension; Vitamin C; Vitamin E

Indexed keywords

ACETYLCYSTEINE; ALDEHYDE DERIVATIVE; ALPHA TOCOPHEROL; ASCORBIC ACID; CALCIUM CHANNEL; CALCIUM ION; CYSTEINE; DRINKING WATER; FRUCTOSE; GLUTATHIONE; MEMBRANE PROTEIN; THIOL GROUP; CALCIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTERIOLE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; CYTOSOL; DIET SUPPLEMENTATION; FRUCTOSE INDUCED HYPERTENSION; HISTOPATHOLOGY; HYPERPLASIA; HYPERTENSION; KIDNEY; NONHUMAN; PROTEIN BINDING; RAT; RAT STRAIN; RENAL ARTERY; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE; ANIMAL; BODY WEIGHT; CHEMICALLY INDUCED DISORDER; DRINKING BEHAVIOR; DRUG EFFECT; FEEDING BEHAVIOR; METABOLISM; ORGAN SIZE; WISTAR KYOTO RAT;

ANIMALIA;

ANIMALS; ASCORBIC ACID; BLOOD PLATELETS; BODY WEIGHT; CALCIUM; DRINKING BEHAVIOR; FEEDING BEHAVIOR; FRUCTOSE; HYPERTENSION; ORGAN SIZE; RATS; RATS, INBRED WKY; VITAMIN E;

EID: 0036892724     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020835229591     Document Type: Article

References (74)

1. Tappel AL: Biological antioxidant protection against lipid peroxidation damage. Am J Clin Nutr 23: 1137-1139, 1970
2. Burton GW, Foster DO, Perly B, Slater TF, Smith ICP, Ingold KU: Biological antioxidants. Phil Trans R Soc Lond [Biol] 311: 565-578, 1985
3. Beamish RE: Vitamin E - then and now. Can J Cardiol 9: 29-30, 1993
4. Grey KF, Puska P, Jordan P, Moser UK: Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 53: 326S-334S, 1991
5. Donnan PT, Thomson M, Fowkes FGR, Prescott RJ, Housley E: Diet as a risk factor for peripheral arterial disease in the general population: The Edinburgh artery study. Am J Clin Nutr 57: 917-921, 1993
6. Costagliola C, Libondi T, Menzione M, Rinaldi E, Auricchio G: Vitamin E and red blood cell glutathione. Metabolism 34: 712-714, 1985
7. Sharma A, Kharb S, Chugh SN, Kakkar R, Singh GP: Evaluation of oxidative stress before and after control of glycemia and after vitamin E supplementation in diabetic patients. Metabolism 49: 160-162, 2000
8. Paolisso G, D'Amore A, Giugliano D, Ceriello A, Varricchio M, D'Onofrio F: Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients. Am J Clin Nutr 57: 650-656, 1993
9. Barbagallo M, Dominguez LJ, Tagliamonte MR, Resnick LM, Paolisso G: Effect of vitamin E and glutathione on glucose metabolism. Role of magnesium. Hypertension 34: 1002-1006, 1999
10. Raghuveer G, Sinkey CA, Chenard C, Stmbo P, Haynes WG: Effect of vitamin E on resistance vessel endothelial dysfunction induced by methionine. Am J Cardiol 88: 285-290, 2001
11. Newaz MA, Nawal NNA: Effect of α-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am J Hypertens 11: 1480-1485, 1998
12. Galley HF, Thornton J, Howdle PD, Walker BE, Webster NR: Combination oral antioxidant supplementation reduces blood pressure. Clin Sci 92: 361-365, 1997
13. Levine M: New concepts in the biology and biochemistry of ascorbic acid. New Eng J Med 314: 892-902, 1986
14. Meister A: Commentary on the antioxidant effects of ascorbic acid and glutathione. Biochem Pharmacol 44: 1905-1915, 1992
15. Sergeev IN, Arkhapchev YP, Spirichev VB: Ascorbic acid effects on vitamin D hormone metabolism and binding in guinea pigs. J Nutr 120: 1185-1190, 1990
16. Paolisso G, D'Amore A, Balbi V, Volpe C, Galzerano D, Guigliano D, Sgambato S, Varrichio M, D'Onofrio F: Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol (Endocrinol Metab 29) 266: E261-E268, 1994
17. Paolisso G, Balbi V, Volpe C, Carricchio G, Gambardello A, Saccomanno F, Ammendola S, Varricchio M, D'Onofrio F: Metabolic benefits deriving from chronic vitamin C supplementation in aged non-insulin dependent diabetics. J Am Coll Nutr 14: 387-392, 1995
18. Meister A: Glutathione-ascorbic acid antioxidant system in animals. J Biol Chem 269: 9397-9400, 1994
19. Yoshioka M, Aoyama K, Matsushita T: Effects of ascorbic acid on blood pressure and ascorbic acid metabolism in spontaneously hypertensive rats (SH rats). Int J Vit Nutr Res 55: 301-307, 1985
20. Ziemlanski S, Wartanowicz M, Potrzebnicka K, Burgos de Moor A, Iwanow K, Ignatowska-Switalska M, Zelakiewicz K: Effect of exogenous ascorbic acid on experimental hypertension and mineral balance in rats fed low- and high-fat diets. Nutrition 7: 131-135, 1991
21. Akpaffiong MJ, Taylor AA: Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. Am J Hypertens 11: 1450-1460, 1998
22. Moran JP, Cohen L, Greene JM, Xu G, Feldman EB, Hames CG, Feldman DS: Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr 57: 213-217, 1993
23. Ness AR, Khaw KT, Bingham S, Day NE: Vitamin C status and blood pressure. J Hypertens 14: 503-508, 1996
24. Ness AR, Chee D, Elliott P: Vitamin C and blood pressure - an overview. J Hum Hypertens 11: 343-350, 1997
25. Bates CJ, Walmsley CM, Prentice A, Finch S: Does vitamin C reduce blood pressure? Results of a large study of people aged 65 or older. J Hypertens 16: 925-932, 1998
26. Lieber CS: Mechanism of ethanol induced hepatic injury. Pharmac Ther 46: 1-41, 1990
27. Sorrell MD, Ruma DJ: The functional implications of acetaldehyde binding to cell constituents. Annals NY Acad Sci 492: 50-70, 1987
28. Vasdev S, Barrett B, Longerich L, Ford CA: Ethanol-induced hypertension: the role of acetaldehyde. In: N.S. Dhalla (ed). Pathophysiology of Heart Failure. Kluwer Academic Publishers, Norwell, MA, USA, 1996, pp 77-93
29. Vasdev S, Longerich L, Ford CA: Role of aldehydes in hypertension. In: B.K. Sharma, N. Takeda, N.K. Ganguly, P.K. Singal (eds). Adaptation Biology and Medicine, vol. I. Narosa Publishing House, New Delhi, India, 1997, pp 326-339
30. Vasdev S, Ford CA, Longerich L, Gadag V, Wadhawan S: Role of aldehydes in fructose induced hypertension. Mol Cell Biochem 181: 1-9, 1998
31. Vasdev S, Mian T, Ford CA, Longerich L, Parai S: Role of endogenous aldehydes in spontaneously hypertensive and disulfiram-induce hypertensive rats. Nutr Metab Cardiovasc Dis 6: 130-140, 1996
32. Sprince H, Parker CM, Smith CG, Gonzales LJ: Protection against acetaldehyde toxicity in the rat by L-cysteine, thiamin and L-2-methylthiazolidine-4-carboxylic acid. Agents Actions 4: 125-129, 1974
33. Meister A. Anderson ME, Hwang O: Intracellular cysteine and glutathione delivery systems. J Am Col Nutr 5: 137-151, 1986
34. Johnston CS, Meyer CG, Srilakshmi JC: Vitamin C elevates red blood cell glutathione in healthy adults. Am J Clin Nutr 58: 103-105, 1993
35. Dillard CJ, Tappel AL: Fluorescent damage products of lipid peroxidation. Meth Enzymol 105: 337-341, 1984
36. Mandal AK, Bell RD, Parker D, Nordquist JA, Lindeman RD: An anaylsis of the relationship of the malignant lesions of the kidney to hypertension. Microvasc Res 14: 279-292, 1977
37. Franco-Obrégon A, Ureòa J, Lòpez-Barneo J: Oxygen-sensitive calcium channels in vascular smooth muscle and their possible role in hypoxic arterial relaxation. Proc Natl Acad Sci 92: 4715-4719, 1995
38. 2+ channel in rabbit heart sarcolemma and skeletal muscle transverse-tubules: Role of disulfide, sulfhydryl and phosphate groups. Biochim Biophys Acta 1052: 333-339, 1990
39. 2+ release from sarcoplasmic reticulum via an oxidation reaction. J Biol Chem 264: 21725-21736, 1989
40. Oba T, Yamaguchi M: Sulfhydryls on frog skeletal muscle membrane participate in contraction. Am J Physiol 259: C709-C714, 1990
41. Schauenstein E, Esterbauer H, Zollner H: In: Aldehydes in Biological Systems, Their Natural Occurrence and Biological Activities. Pion Limited, London, 1977, pp 1-7
42. Bolli P, Erne P, Hulthen UL, Ritz R, Kiowski W, Ji BH, Buhler FR: Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and β-adrenoceptor blockade. J Cardiovasc Pharmac 6: S996-S1001, 1984
43. Pollard TD: Electron microscopy of synthetic myosin filaments. J Cell Biol 67: 93-104, 1975
44. Vasdev S, Ford CA, Longerich L, Parai S, Gadag V, Wadhawan S: Aldehyde induced hypertension in rats: Prevention by N-acetyl cysteine. Artery 23: 10-36, 1998
45. Thornalley PJ: Modification of the glyoxalase system in disease processes and prospects for therapeutic strategies. Biochem Soc Trans 21: 531-534, 1993
46. Phillips SA, Mirlees D, Thornalley PJ: Modification of the glyoxalase system in streptozotocin-induced diabetic rats. Effect of the aldose reductase inhibitor statil. Biochem Pharmacol 46: 805-811, 1993
47. Kumar KV, Das UN: Are free radicals involved in the pathobiology of human essential hypertension? Free Rad Res Commun 19: 59-66, 1993
48. Wen Y, Killalea S, McGettigan P, Feely J: Lipid peroxidation and anti-oxidant vitamins C and E in hypertensive patients. Irish J Med Sci 165: 210-212, 1996
49. Bendich A, Gabriel E, Machlin LJ: Differences in vitamin E levels in tissues of the spontaneously hypertensive and Wistar-Kyoto rats (41560). Proc Soc Exp Biol Med 172: 297-300, 1983
50. Ito H, Torii M, Suzuki T: A comparative study on defense systems for lipid peroxidation by free radicals in spontaneously hypertensive and normotensive rat myocardium. Comp Biochem Physiol 103B: 37-40, 1992
51. Janero DR, Burghardt B: Cardiac membrane vitamin E and malondialdehyde levels in heart muscle of normotensive and spontaneously-hypertensive rats. Lipids 24: 33-38, 1989
52. Uysal M, Bulur H, Sener D, Öz H: Lipid peroxidation in patients with essential hypertension. Int J Clin Pharmacol Ther Toxicol 24: 474-476, 1986
53. Pierdomenico SD, Costantini F, Bucci A, De Cesare D, Cuccurullo F, Mezzetti A: Low density lipoprotein oxidation and vitamins E and C in sustained and white-coat hypertension. Hypertension 31: 621-626, 1998
54. Poli G, Dianzani MU, Cheeseman KH, Slater TF, Lang J, Esterbauer H: Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride or ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem J 227: 629-638, 1985
55. Dargel R: Lipid peroxidation - a common pathogenetic mechanism? Exp Toxic Pathol 44: 169-181, 1992
56. Newaz MA, Newal NNA, Rohaizan CH, Muslim N, Gaper A: α-Tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats. Am J Hypertens 12: 839-844, 1999
57. Anurag P, Anuradha CV: Metformin improves lipid metabolism and attenuates lipid peroxidation in high fructose-fed rats. Diabetes Obes Metab 4: 36-42, 2002
58. Vasdev S, Ford CA, Parai S, Longerich L, Gadag V: Dietary vitamin C supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem 218: 97-103, 2001
59. Vasdev S, Gill V, Parai S, Longerich L, Gadag V: Dietary vitamin E supplementation lowers blood pressure in spontaneously hypertensive rats. Mol Cell Biochem, 2002 (in press)
60. Szczeklik A, Gryglewski RJ, Domagala R, Basista M: Dietary supplementation with vitamin E in hyperlipoproteinemias: Effect on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemostas 52: 425-430, 1985
61. Reaven GM, Hoffman BB: Abnormalities of carbohydrate metabolism may play a role in the etiology and clinical course of hypertension. Tr Pharmacol Sci 9: 78-79, 1998
62. Hulman S, Falkner B, Freyvogel N: Insulin resistance in the conscious spontaneously hypertensive rat: Euglycemic hyperinsulinemic clamp study. Metabolism 42: 14-18, 1993
63. Zemel MB, Reddy S, Sowers JR: Insulin attenuation of vasoconstriction responses to phenylephrine in zucker lean and obese rats. Am J Hypertens 4: 537-539, 1991
64. Hwang IS, Ho H, Hoffman BB, Reaven GM: Fructose-induced insulin resistance and hypertension in rats. Hypertension 10: 512-516, 1987
65. Bhanot S, McNeill JH, Bryer-Ash M: Vanadyl sulfate prevents fructose-induced hyperinsulinemia and hypertension in rats. Hypertension 23: 308-312, 1994
66. Leonicini G, Maresca M, Buzzi E: Inhibition of the glycolytic pathway of methylglyoxal in human platelets. Cell Biochem Funct 7: 65-70, 1989
67. Paolisso G, Di Maro G, Pizza G, D'Amore A, Sgambato S, Tesauro P, Varrichio M, D'Onofrio F: Plasma GSH/GSSG affects glucose homeostasis in healthy subjects and non-insulin-dependent diabetics. Am J Physiol 263 (Endocrinol Metab 26): E435-E440, 1992
68. Solzbach U, Hornig B, Jeserich M, Just H: Vitamin C improves endothelial function of epicardial coronary arteries in hypertensive patients. Circulation 96: 1513-1519, 1997
69. Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A: Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 97: 2222-2229, 1998
70. Miatello R, Risler N, Castro C, Gonzalez S, Ruttler M, Cruzado M: Aortic smooth muscle cell proliferation and endothelial nitric oxide synthase activity in fructose-fed rats. Am J Hypertens 14: 1135-1141, 2001
71. Dumont AS, Hyndman ME, Dumont RJ, Fedak P, Kassell NF, Sutherland GR, Verma S: Improvement of endothelial function in insulin-resistant carotid arteries treated with pravastatin. J Neurosurg 95: 466-471, 2001
72. Kanani PM, Sinkey CA, Browning RL, Allaman M, Knapp HR, Haynes WG: Role of oxidant stress in endothelial dysfunction produced by experimental hyperhomocysteinemia in humans. Circulation 100: 1161-1168, 1999
73. Chambers JC, McGregor A, Jean-Marie J, Obeid OA, Kooner JS: Demonstration of rapid onset vascular endothelial dysfunction after hyperhomocysteinemia: an effect reversible with vitamin C therapy. Circulation 99: 1156-1160, 1999
74. Varizi ND, Wang XQ, Oveisi F, Rad B: Induction of oxidative stress by glutathione depletion causes severe hypertension in normal rats. Hypertension 36: 142-146, 2000